Interventions for chronic non-hypovolaemic hypotonic hyponatraemia

This review aims to look at the benefits and harms of interventions for chronic non-hypovolaemic hypotonic hyponatraemia when compared with placebo, no treatment or head-to-head.

The review aims to determine if benefits and harms vary in absolute or relative terms dependent on the specific compound within a drug class, on the dosage used, or the underlying disorder causing the hyponatraemia.

This is a protocol.

Share/Save